IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
85.17
-1.77 (-2.04%)
Nov 10, 2026, 4:00 PM EST - Market closed
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, IRADIMED CORPORATION stock has a consensus rating of "Buy" and an average price target of $118. The average 1-year stock price forecast is 38.55% higher than the current stock price, while the lowest is $116 (+36.20%) and the highest is $120 (+40.89%).
Price Target: $118 (+38.55%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 3, 2026.
Analyst Ratings
The average analyst rating for IRADIMED CORPORATION stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 22, 2026 |
| Lake Street | Lake Street | Buy Reiterates $120 | Buy | Reiterates | $120 | +40.89% | Aug 3, 2026 |
Financial Forecast
Revenue This Year
91.93M
from 83.81M
Increased by 9.69%
Revenue Next Year
102.30M
from 91.93M
Increased by 11.28%
EPS This Year
2.10
from 1.93
Increased by 8.64%
EPS Next Year
2.44
from 2.10
Increased by 16.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.